Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 5 minute read Pharma Industry News What the end of the Kowa partnership signals for Arcutis Biotherapeutics’ commercial control of ZORYVE Arcutis Biotherapeutics ends its Kowa partnership and takes full control of ZORYVE promotion. Find out what this signals for adoption and strategy. bySoujanya RaviJanuary 29, 2026